Symptoms of lupus include painful swollen joints, fever, rashes and chest pain ... This included an existing Janssen treatment, STELARA® (ustekinumab), which is approved for the treatment ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- First-dose reactions to IV ustekinumab (Stelara) may be related to IgE recognition of a carbohydrate ...

Yesintek, a Stelara biosimilar, received FDA approval for IBD, plaque psoriasis, and psoriatic arthritis, with a launch expected in late 2025. Clinical trials confirmed Yesintek's equivalence to ...

Ustekinumab-stba is approved for multiple conditions, showing comparable efficacy and safety to Stelara in clinical trials. The biosimilar will be available in subcutaneous and intravenous forms ...

The FDA has approved Celltrion’s Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), for subcutaneous or intravenous use in adults and pediatric patients with plaque psoriasis and ...

Cigna's (NYSE:CI) pharmacy benefit manager, Evernorth Health Services, announced on Thursday plans to launch a biosimilar to ...